HOME >> BIOLOGY >> NEWS
Colon Cancer Alliance launches interactive support program

CHICAGO September 14, 2006 -- Every four minutes someone in the United States is diagnosed with colorectal cancer, a diagnosis that can be overwhelming without appropriate information and support. People living with colorectal cancer now have the opportunity to exchange ideas and information with experts in the field and fellow patients through an educational workshop series called "Conversations About Colorectal Cancer." The program launches this weekend at the Colon Cancer Alliance's (CCA) 6th Annual Colorectal Cancer Conference in Chicago.

The two-day interactive conference will allow patients to have a dialogue with thought-leading physicians in the area of colorectal cancer on a range of topics, from the latest treatment advances with targeted therapies to managing their side effects. In addition, patients and caregivers will have the opportunity to listen to, and support one another, in their collective battle against colorectal cancer.

"This program is an important way for those living with colorectal cancer to learn more about the nation's second-leading cancer killer," says Amy Kelly, Co-Founder and Executive Director of the Colon Cancer Alliance. "By encouraging increased dialogue between patients, health care providers and caregivers, we hope to help patients learn how to successfully continue their daily activities and ultimately improve their quality of life."

According to a Harris Interactive survey of more than 500 cancer patients and 300 oncologists, patients who held discussions with their physicians about cancer topics were more knowledgeable about their condition than those who did not hold discussions. For example, only 10 percent of patients who did not participate in dialogue with their physician were knowledgeable about the extent of available treatment options. In addition, patients who did not have discussions with their physician were less knowledgeable about the possibility of treatment delays, infe
'"/>

Contact: Amy E. Kelly
akelly@ccalliance.org
954-341-0212
Porter Novelli
14-Sep-2006


Page: 1 2

Related biology news :

1. Smithsonian Fragmentation Project threatened by Amazon Colonization Plan
2. Kidnapped: Colon cancer seizes hapless nerve growth protein
3. Journalists can register now for ECCO 14 -- the European Cancer Conference
4. Cancer cures could work for canines and humans
5. The Cancer Genome Atlas awards funds for technology development
6. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
7. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
8. Cancer stem cells can go it alone
9. Cancer drug enhances long-term memory
10. Cancer cells reprogram energy needs to grow and spread, study suggests
11. Cancer scientists create human leukemia process to map how disease begins, progresses

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Colon Cancer Alliance launches interactive support program

(Date:10/15/2014)... from strains of influenza virus increases with the latest ... complacent that the most substantial threats have been identified, ... arise when a new virus strain – against which ... in the human population. There have been five such ... which – the 1918 Spanish Flu – cost 50 ...
(Date:10/15/2014)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... growing mobile commerce market releases photos and video of the recent ... October 13 th . Gino Pereira , ... angel investor Mr. Chad A. Verdi rang the bell.  ... his investors and employees "for their work and dedication in bringing ...
(Date:10/14/2014)... of years since T. rex took its ... scientists is breathing life back into dinosaurs using high-powered ... research has important implications for how dinosaurs used their ... sense of smell and cool their brains. , ... student Jason Bourke, lead author of the new study ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3
(Date:10/25/2014)... (PRWEB) October 24, 2014 The ... the nation’s leading nonprofit authority on the use ... information exchange, announces its appointment of four new ... The workgroup leaders include:, ,     Peter ...     Erik Pupo, Specialist Leader, Deloitte Consulting LLP ...
(Date:10/25/2014)... (PRWEB) October 24, 2014 SonaCare ... focused ultrasound (HIFU) technology, announced that its Board ... as Chief Executive Officer, President and member of ... Dr. Carol will take-on expanded responsibilities within the ... as well as overseeing commercialization, manufacturing and finance. ...
(Date:10/25/2014)... , October 24, 2014 ... clinical-stage pharmaceutical company focused on the development of oral ... Nadav Kidron will present at FireRock Capital,s ... Capital,s Annual Micro-Cap Conference ,Date: Tuesday, October 28, 2014 ... New York City , ...
(Date:10/25/2014)... -- Investor-Edge has initiated coverage on the ... Vertex Pharmaceuticals Inc. (NASDAQ: VRTX ), Alexion ... Inc. (NASDAQ: PPHM ), and StemCells Inc. ... be accessed at: http://investor-edge.com/register . The ... a positive note as the Dow Jones Industrial Average ...
Breaking Biology Technology:WEDI Appoints Four New Security and Privacy Workgroup Co-chairs 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 3Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5
Cached News: